Overall Status

Active, not recruiting (1)

Terminated (1)

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Celldex Therapeutics (1)

Medical College of Wisconsin (1)

Collaborator

Blood and Marrow Transplant Clinical Trials Network (1)

National Cancer Institute (NCI) (1)

National Heart, Lung, and Blood Institute (NHLBI) (1)

National Marrow Donor Program (1)

Intervention

cdx-301 (1)

cdx-301 and plerixafor (1)

cyclophosphamide (1)

methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/methotrexate (1)

mobilized peripheral blood stem cell graft with tacrolimus/mycophenolate mofetil/post-transplant cyclophosphamide (1)

mycophenolate mofetil (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

chronic myelogenous leukemia (cml)

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

Active, not recruiting

Acute Leukemia
+3 more

Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
+5 more

Birmingham, Alabama
+38 more

Oct 25, 2021

For Donors, Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling, For Recipients Trial in United States

Terminated

For Donors
+9 more

CDX-301
CDX-301 and plerixafor

Los Angeles, California
+7 more

Apr 6, 2017